Aarti Drugs Limited — Call Transcript 2020

May 15, 2020

==> picture [477 x 82] intentionally omitted <==

Ref: ADL/SE/2020-21 May 15, 2020

To, Listing/ Compliance Department BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001

To, Listing/ Compliance Department National Stock Exchange of India Limited, “Exchange Plaza”, Bandra - Kurla Complex, Bandra (E), Mumbai – 400051

BSE CODE – 524348

NSE SYMBOL: AARTIDRUGS

Dear Sir/Madam,

Ref : Regulation 30(6) of SEBI (LODR) Regulations, 2015 Sub: Intimation of Conference Call

This is to inform you that Quarterly Conference Call for the Investors and Analysts has been scheduled on Monday, May 18, 2020 at 3:00 PM IST to discuss the Company’s Q4 FY20 Results. Please find attached herewith invitation for the same.

Kindly take the same on record.

Thanking you,

Yours faithfully,

FOR AARTI DRUGS LIMITED

DEOLE Digitally signed by DEOLE RUSHIKESH RUSHIKESH VIVEK Date: 2020.05.15 VIVEK 18:28:44 +05'30' RUSHIKESH DEOLE COMPANY SECRETARY & COMPLIANCE OFFICER ICSI M.No.: A54527

==> picture [468 x 32] intentionally omitted <==

Centrum Broking Limited Cordially invites you to a

Conference Call

with Management of

Aarti Drugs Ltd.

Agenda: Discussion on Q4FY20 results & future outlook

			Company Management
			Mr. Harshit Savla		Jt. Managing Director
			Mr. Harit Shah		Wholetime Director
			Mr. Adhish Patil		CFO
			Conference Dial-In Numbers
			Primary Number:		+91 22 6280 1210 / +91 22 7115 8111
			Secondary Number:		+91 -7045671221
					USA : 1 866 746 2133
			International Toll Free Numbers:		UK : 0 808 101 1573Singapore : 800 101 2045
					Hong Kong : 800 964 448
			Date:		Monday, 18 May2020
			Time:		03.00 PM IST
			RSVP:
			Ms. Cyndrella Carvalho
			Centrum Broking Limited
			Land line: +91 22 4215 9643
			Mob: +91 9823 615656
			E-mail:cyndrella.carvalho@centrum.co.in